- Perspective on the debate over regulating stem cell clinics, the launch of CRL's CRISPR services, a way to end cholera in Haiti.
December 9, 2016
BY: Eureka Staff
What Type of Chemist Are You?
December 2, 2016
BY: Stephen Penrose
- The first decline since 1993 is likely being driven by multiple factors, including obesity.
December 8, 2016
BY: Eureka Staff
- CRISPR for the development of organoids or PDX, and novel immunomodulatory, combination therapies. What our cancer scientists are eyeing in the coming year.
December 5, 2016
BY: Eureka Staff
- The pros and cons of an animal studies database, the latest on three-parent IVF and a crucial vote on the US Cures Act.
December 2, 2016
BY: Eureka Staff
- Deep learning's deepening impact on drug discovery and free energy simulations in industrial computer-aided drug design. What our chemists are looking for in the coming year.
December 1, 2016
BY: Eureka Staff
- How much progress are we making toward solving this neurological disorder? Scientists from Charles River Laboratories and Teva Pharmaceuticals discuss the state of the science. Listen and learn.
November 29, 2016
BY: Eureka Staff
- Trying to stop genetic manipulation of the human genome is futile, so let’s learn to use it wisely.
November 28, 2016
BY: Iva Morse
- Trial clouds amyloid beta theory, what might be causing food coma, and why yo-yo dieting doesn't work.
November 25, 2016
BY: Eureka Staff
- Diversity-oriented synthesis leads to a promising new compound for the single-dose treatment of malaria.
November 21, 2016
BY: David Clark